Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly known as aspirin) has been the mainstay of treatment for decades owing to its capacity to reduce the risk of ischaemic events. Accordingly, novel antithrombotic therapies have been traditionally tested on a ba...

Celý popis

Podrobná bibliografia

Vydané v:	Nature reviews cardiology Ročník 15; číslo 8; s. 480 - 496
Hlavní autori:	Capodanno, Davide, Mehran, Roxana, Valgimigli, Marco, Baber, Usman, Windecker, Stephan, Vranckx, Pascal, Dangas, George, Rollini, Fabiana, Kimura, Takeshi, Collet, Jean-Philippe, Gibson, C Michael, Steg, Philippe Gabriel, Lopes, Renato D, Gwon, Hyeon-Cheol, Storey, Robert F, Franchi, Francesco, Bhatt, Deepak L, Serruys, Patrick W, Angiolillo, Dominick J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Nature Publishing Group 01.08.2018
Predmet:	Acids Aspirin - therapeutic use Cardiovascular disease Cardiovascular Diseases - drug therapy Cardiovascular Diseases - prevention & control Disease prevention Fibrinolytic Agents - therapeutic use Humans Stroke Stroke - drug therapy Stroke - prevention & control
ISSN:	1759-5002, 1759-5010, 1759-5010
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!